IDEAYA Biosciences
IDYA
112 hedge funds and large institutions have $677M invested in IDEAYA Biosciences in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 22 reducing their positions, and 12 closing their positions.
711,300% more call options, than puts
Call options by funds: $7.11M | Put options by funds: $1K
133% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 12
114% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 22
38% more capital invested
Capital invested by funds: $489M → $677M (+$188M)
17% more funds holding
Funds holding: 96 → 112 (+16)
5.04% more ownership
Funds ownership: 91.7% → 96.74% (+5%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$22.7M |
| 2 |
DM
Deerfield Management
New York
|
+$22.6M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$21.7M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$13.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$9.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$20.8M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
-$10.4M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
-$2.62M |
| 4 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$2.39M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$1.8M |
IDYA Hedge Fund Activity: Q3 2022 in Review
112 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2022, worth a combined $677M — up 38% from $489M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new IDYA positions and 12 closed out — a net gain of 16 holders — while 47 added to existing stakes and 22 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $22.7M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $20.8M sold.
- 112 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2022, up from 96 in Q2 2022.
- Funds reported $677M of IDEAYA Biosciences stock for Q3 2022, up 38% quarter-over-quarter.
- 28 funds opened new IDEAYA Biosciences positions in Q3 2022 and 12 closed out, a net change of +16 holders.
- The largest IDEAYA Biosciences buyer in Q3 2022 was Adage Capital Partners, an estimated $22.7M added.
- The largest IDEAYA Biosciences seller in Q3 2022 was Point72 Asset Management, an estimated $20.8M sold.
Based on aggregated 13F filings for Q3 2022.